| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 37.961 | 55.920 | 67.359 | 62.623 | 61.269 |
| Total Income - EUR | - | - | - | - | - | 37.961 | 55.920 | 67.359 | 64.614 | 61.269 |
| Total Expenses - EUR | - | - | - | - | - | 28.676 | 41.181 | 58.202 | 46.540 | 45.957 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 9.285 | 14.739 | 9.158 | 18.074 | 15.312 |
| Net Profit/Loss - EUR | - | - | - | - | - | 8.931 | 14.180 | 8.585 | 17.525 | 13.749 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Med Cardio Maria Florescu S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 12.886 | 9.164 | 5.745 | 0 | 655 |
| Current Assets | - | - | - | - | - | 11.836 | 33.576 | 42.724 | 64.703 | 71.981 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 21.389 | 35.306 | 59.692 | 70.362 |
| Cash | - | - | - | - | - | 11.836 | 12.187 | 7.418 | 5.011 | 1.620 |
| Shareholders Funds | - | - | - | - | - | 8.972 | 22.953 | 31.182 | 48.613 | 62.090 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 15.750 | 19.787 | 17.288 | 16.090 | 10.546 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Med Cardio Maria Florescu S.r.l.